Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last --
Change Today 0.00 / 0.00%
Volume 0.0
PTW On Other Exchanges
All times are local (Market data is delayed by at least 15 minutes).

petroworth resources inc (PTW) Snapshot

Previous Close
Day High
Day Low
52 Week High
-- - --
52 Week Low
-- - --
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield

Related News

No related news articles were found.

petroworth resources inc (PTW) Related Businessweek News

No Related Businessweek News Found

petroworth resources inc (PTW) Details

M Pharmaceutical Inc., a clinical-stage company, develops and commercializes biomedical technologies for the monitoring and treatment of obesity, diabetes, and other gastroenterological indications in Canada. It holds rights to three technologies, such as Trimeo capsules, which are temporary controllable pseudobezoars for non-invasive gastric volume reduction for the treatment of obesity; Trimtec gastrointestinal functional neurostimulators that are implanted laparoscopically for the treatment of obesity and gastroparesis without permanent anatomical modification of the stomach; and eMosquito wearable blood monitor product for automatic and autonomous monitoring of blood glucose by diabetics. The company was formerly known as First Sahara Energy Inc. and changed its name to M Pharmaceutical Inc. in November 2014. M Pharmaceutical Inc. was founded in 2003 and is headquartered in Vancouver, Canada.

Founded in 2003

petroworth resources inc (PTW) Top Compensated Officers

Chief Financial Officer
Total Annual Compensation: C$17.8K
Compensation as of Fiscal Year 2013.

petroworth resources inc (PTW) Key Developments

M Pharmaceutical Inc. Announces Management Changes

M Pharmaceutical Inc. announced the appointment of Matthew B. Lehman as President and Chief Executive Officer, effective September 1, 2015. Mr. Lehman brings over 15 years of executive level experience in the development of therapeutics to his new role. Dr. Martin Mintchev, the lead inventor of the company's technologies and Company co-founder, will transition from his position as CEO to serve as Chief Scientific Officer. Most recently, Mr. Lehman was the CEO of Prima Biomed Ltd. As of September 1, 2015, Mr. Lehman will also be appointed to the Company's Board of Directors.

M Pharmaceutical Inc. to Open a Fully Owned Subsidiary in Sofia, Bulgaria

M Pharmaceutical Inc. announced that its Board of Directors has made a decision to open a fully owned subsidiary company M Pharma Bulgaria Ltd. with a clear mandate to achieve registration of the Company's temporary controllable pseudobezoar technology Trimeo as a medical device in the European Union, and to obtain a CE Mark for it. M Pharma Bulgaria will collaborate with Medica AD (Bulgaria), a leading producer of CE certified medical materials in Eastern Europe, and with local vendors to achieve these objectives.

Rishena Enters Into Manufacturing Supply Agreement for Production of Trimtec Gastric Stimulation Device

M Pharmaceutical Inc. announced that it has entered into a manufacturing supply agreement with Rishena Co., Ltd., to manufacture the company's Trimtec gastric functional neurostimulation device. Under the terms of the agreement, Rishena will be the exclusive supplier of laparoscopically-implantable Trimtec devices to M Pharmaceutical for the North and South American markets. The devices will be fully programmable and rechargeable through an abdominal belt.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
PTW:CN C$0.00 CAD 0.00

PTW Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for PTW.
View Industry Companies

Industry Analysis


Industry Average

Valuation PTW Industry Range
Price/Earnings NM Not Meaningful
Price/Sales -- Not Meaningful
Price/Book 1.4x
Price/Cash Flow NM Not Meaningful
TEV/Sales -- Not Meaningful

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact PETROWORTH RESOURCES INC, please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at